PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer

Conclusion: This study demonstrated that PSMA-11–derived dual-labeled dye conjugates are feasible for providing PSMA-specific pre-, intra-, and postoperative detection of prostate cancer lesions and have high potential for future clinical translation.

Source: Journal of Nuclear Medicine - April 2, 2018 Category: Nuclear Medicine Authors: Baranski, A.-C., Schafer, M., Bauder-Wust, U., Roscher, M., Schmidt, J., Stenau, E., Simpfendorfer, T., Teber, D., Maier-Hein, L., Hadaschik, B., Haberkorn, U., Eder, M., Kopka, K. Tags: Basic Source Type: research